Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1914 of 5804
-
Brain stimulation for nerve pain: scientists map electrode placement to improve relief
Knowledge-focused Recruiting nowCortical stimulation has been used since 1991 to treat neuropathic pain. However, the underlying mechanisms are still incompletely understood and under-studied. In this protocol, the investigators aim to study the myeloarchitectonic and functional characteristics of areas activat…
Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC
-
Can rewards for personal goals reduce meth overdoses?
Disease control OngoingThe main goal of this study is to tests the effect of incentivizing achievement of self-identified, personal harm reduction goals (Contingency management or CM) compared with standard of care (peer harm reduction service with incentives for peer visits) to increase the reach and …
Phase: NA • Sponsor: Oregon Health and Science University • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
New heart scan method could catch hidden lung pressure earlier
Diagnosis OngoingThis study aims to assess the application of the novel IMPULSE algorithm for the detection of pulmonary hypertension (PH) in those with a low or intermediate probability of PH according to the British Society of Echocardiography (ESC) and European Society of Cardiology (ESC) guid…
Sponsor: Royal United Hospitals Bath NHS Foundation Trust • Aim: Diagnosis
Last updated Jul 03, 2026 00:00 UTC
-
New outreach program targets mental health gaps in latino communities
Symptom relief OngoingLatinos in the U.S. experience significant disparities in access to mental health services due to lack of health insurance, language barriers, low availability of bilingual providers, mental health stigma, and fear of deportation. There is an urgent need to identify low-cost, cul…
Phase: NA • Sponsor: Drexel University • Aim: Symptom relief
Last updated Jun 27, 2026 12:07 UTC
-
New vaccine trial aims to shield korean babies from deadly meningitis
⭐️ VACCINE ⭐️ OngoingThe purpose of this study is to assess the safety and immune responses of rMenB+OMV NZ vaccine when administered to healthy infants from 2 months in the Republic of Korea according to a 2-dose primary schedule and 1 booster dose.
Phase: PHASE4 • Sponsor: GlaxoSmithKline • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:04 UTC
-
New daily pill aims to improve blood sugar in type 2 diabetes
Disease control CompletedThe main purpose of this study is to determine the safety and efficacy of orforglipron. Participants will have Type 2 Diabetes (T2D) and have inadequate glycemic control with insulin glargine with or without metformin and/or SGLT-2 (sodium-glucose cotransporter-2) inhibitor. The …
Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Mind over long COVID: new study tests behavioral relief
Symptom relief Recruiting nowThe goal of this study is to determine if a mind-body intervention can help people suffering from symptoms associated with Long COVID. The study is a randomized trial examining the effectiveness of a mind body intervention in reducing somatic symptoms from Long COVID in participa…
Phase: NA • Sponsor: Beth Israel Deaconess Medical Center • Aim: Symptom relief
Last updated Jun 27, 2026 09:05 UTC
-
Could MS patients switch to once-yearly infusions? new trial aims to find out
Disease control Recruiting nowMultiple sclerosis (MS) is a chronic autoimmune disease of the central nervous system and the leading cause of severe non-traumatic disability in young people, affecting 110,000 people in France. Ocrelizumab, a humanized anti-CD20 monoclonal antibody, has shown remarkable efficac…
Phase: PHASE3 • Sponsor: Fondation Ophtalmologique Adolphe de Rothschild • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Brain scans reveal LSD's grip on serotonin receptors
Knowledge-focused OngoingThe investigators wish to quantify the relation between administered dose of lysergic acid diethylamide (LSD), plasma LSD levels, and occupancy at the serotonin 2A receptor (5-HT2AR) using \[11C\]CIMBI-36 positron emission tomography.
Phase: EARLY_PHASE1 • Sponsor: Rigshospitalet, Denmark • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
New pill could help menopausal women sleep through the night
Symptom relief CompletedResearchers are looking for a better way to treat women who have sleep disturbances associated with menopause. Menopause is part of a natural aging process and happens when women's menstrual cycles, also called periods, stop. Sleep disturbances, for example, frequent waking up a…
Phase: PHASE2 • Sponsor: Bayer • Aim: Symptom relief
Last updated Jun 27, 2026 07:56 UTC
-
Could a diabetes pill ease heart failure in fontan patients?
Disease control CompletedThe goal of this clinical trial is to study if an investigational study drug called Dapagliflozin could prevent heart failure from getting worse in adults with Fontan circulation. The main questions it aims to answer are: 1. Does Dapagliflozin decrease Fontan pressure? 2. Does D…
Phase: PHASE4 • Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Monthly pill could revolutionize HIV prevention
Prevention CompletedThis double-blind, placebo-controlled study was designed to assess the safety, tolerability, and pharmacokinetics of oral MK-8527 taken once monthly (QM) in participants at low risk for human immunodeficiency virus Type 1 (HIV-1) infection.
Phase: PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Prevention
Last updated Jun 27, 2026 08:09 UTC
-
New urine test could spot bladder tumors more accurately
Diagnosis CompletedThe study will be offered to all consecutive patients undergoing scheduled cystoscopy at the Hospitalisation De Jour (HDJ) Chirurgicale, either as part of a diagnostic approach in the event of suspected bladder tumor (exploration of macroscopic hematuria in particular), or as par…
Sponsor: Institut Paoli-Calmettes • Aim: Diagnosis
Last updated Jun 27, 2026 11:02 UTC
-
New digital tests aim to spot dementia sooner in seniors
Diagnosis Recruiting nowThe specific aim of the pragmatic trial is to evaluate the practical utility and effect of the PDM, the QDRS, and the combined approach (PDM + QDRS) in improving the annual rate of new documented ADRD diagnosis in primary care practices.
Phase: NA • Sponsor: Indiana University • Aim: Diagnosis
Last updated Jun 27, 2026 07:55 UTC
-
Gene-Editing breakthrough offers hope for blood disorder patients
Disease control CompletedThe goal of this open label, single-arm clinical study is to learn about the safety and efficacy of base-edited autologous hematopoietic stem cell transplantation(CS-101) in treating patients with β-thalassemia major.
Phase: EARLY_PHASE1 • Sponsor: Children's Hospital of Fudan University • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New CT-Based method could predict hip fractures before they happen
Diagnosis Recruiting nowThe clinical study is aimed at assessing the accuracy of the in silico methodology BBCT-hip. BBCT-hip takes as inputs the subject-specific height and weight, and the CT scan of his femur to predict the risk of fracture for the femur upon falling. In the study, 150 subjects who su…
Sponsor: Istituto Ortopedico Rizzoli • Aim: Diagnosis
Last updated Jun 27, 2026 12:36 UTC
-
Blood sugar swings after a heart attack may reveal hidden dangers
Knowledge-focused Recruiting nowDisorders of glycemic regulation are common in patients hospitalized for acute coronary syndrome (ACS). Abnormal glycaemia is observed in 50% of cases, in 30-40% diabetes, and in 25-35% fasting hyperglycaemia or glucose intolerance. Hyperglycemia is a major prognostic factor in …
Phase: NA • Sponsor: University Hospital, Montpellier • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:07 UTC
-
New drug combo may reduce side effects in kidney transplant recipients
Disease control CompletedThe purpose of this study is to find out if there is a difference in how well the standard MUSC cytomegalovirus (CMV) prevention medicine works, compared to a different medicine, in preventing CMV infections in kidney transplant recipients who are at risk for this type of infecti…
Phase: PHASE4 • Sponsor: Medical University of South Carolina • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
New oxygen-based test could prevent kidney damage from blood transfusions in ICU
Disease control Recruiting nowIn critically ill patients, optimized strategies for red blood cells transfusion (RBCT) are still controversial. Most recent guidelines suggest that clinical practice in ICU setting should follow a restrictive approach to RBCT (i.e., hemoglonim level \< 7.0 g/dL).In our previous …
Phase: NA • Sponsor: Università degli Studi di Ferrara • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Scientists dive deep into mesothelioma tumors to unlock new treatment clues
Knowledge-focused Recruiting nowPleural and peritoneal mesotheliomas (PPM) are rare cancers mostly related to asbestos-exposure, which are characterized by a complex histopathological diagnosis and staging, few therapeutic options and a dismal prognosis. The main unmet medical need in PPM is the lack of a treat…
Sponsor: Istituto Oncologico Veneto IRCCS • Aim: Knowledge-focused
Last updated Jun 26, 2026 14:08 UTC